Due to the plasticity and possibly infinite ability for self-renewal, stem cell-derived CD4+CD25+ Treg cells likely are applicable for Treg cell-based immunotherapy, such as autoimmune disorders. This evidence concerns the gene CD4 and autoimmune disease.